OncoMed Pharma (OMED) Gains Sharply on Stemcentrx Deal
Tweet Send to a Friend
OncoMed Pharma (NASDAQ: OMED) is sharply higher (+20.5%) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
